No Data
No Data
TD Cowen Maintains Waldencast(WALD.US) With Hold Rating, Maintains Target Price $4.3
TD Cowen Keeps Their Hold Rating on Waldencast Acquisition (WALD)
Top Premarket Decliners
Waldencast Announces Participation in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit
Insiders Are the Top Stockholders in Waldencast Plc (NASDAQ:WALD), and the Recent 13% Drop Might Have Disappointed Them
Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD Collection